Drug and Device Development
Drug and Device Development Service
The Drug and Device Development Service exists to advance cutting edge therapies and technologies generated by the Stanford community to benefit the advancement of care to mothers and children.
Regulatory Strategy
Target Profile Development
Path from Bench to Bedside
Market Assessment
Existing/Competing Solutions
Market Sizing and Clinical Impact
Project Management
Timeline Development
Budget Building/Tracking
Regulatory Interactions
IND/IDE Preparation and Maintenance
Funding Opportunities
Exploration and Evaluation
Innovation
Business Development
Engagement with VC and Industry
EDUCATION
MCHRI designs and coordinates educational opportunities to benefit translational medicine scientists at Stanford, featuring:
Career Development
Eureka Certificate Course in Translational Medicine
Drug & Device Development (D3) Training
Topic Discussions
Webinars and Live Presentations
Contact
Grant Wells, MS
Director of Innovation & Development
gwells2@stanford.edu